MA
SILK

MYDA Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

MYDA Advisors’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-30,000
Closed -$1.21M – 179
2019
Q4 		$1.21M Buy
30,000
+16,000
+114% +$560K 0.53% 51
2019
Q3 		$455K Sell
14,000
-45,100
-76% -$1.8M 0.21% 68
2019
Q2 		$2.86M Buy
+59,100
New +$2.51M 0.97% 26

Other funds holding SILK

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

MYDA Advisors's SILK Position: Q1 2020 in Review

MYDA Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2020, closing a stake of 30,000 shares — an estimated $1.21M sold.

MYDA Advisors first reported a position in SILK in Q2 2019 and held it in 3 quarters. The position peaked at $2.86M in Q2 2019. 125 funds tracked by Wall St. Rank hold SILK as of Q1 2020.

  • MYDA Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • MYDA Advisors sold 30,000 Silk Road Medical, Inc. Common Stock shares in Q1 2020, an estimated $1.21M.
  • MYDA Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
  • MYDA Advisors's Silk Road Medical, Inc. Common Stock position peaked at $2.86M in Q2 2019.
  • 125 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2020.

Based on MYDA Advisors's 13F filing for Q1 2020, filed 14 May 2020.